Abstract:The so called modern electrocardiography (ECG) is more than 80 years old. It is well known that ECG is affected by a biasing error almost since its inception that may play a fundamental role in the diagnosis of cardiac diseases. Our hypothesis is that our recent advances in electrocardiography technologies (NeoCG) can minimize this biasing error and achieve more precise and prompt diagnosis of deadly cardiac diseases. The Current electrocardiography devices market is >US$1.5billions p.a. and is dominated by 7 major manufacturer. NeoCG once proved may gather the status of monopoly in the future ECG devices market.